CRX.L Regulatory News (CRX)

14 Nov 2005 16:40

Cyprotex PLC14 November 2005 For Immediate Release 14 November 2005 Cyprotex PLC Issue of 10,633,623 shares pursuant exercise of options Cyprotex PLC (AIM: CRX), the provider of pharmacokinetic technology andinformation, today announces that it has issued 10,633,623 new ordinary sharesof 0.1 pence each ("new Ordinary Shares") pursuant to the exercise of options. The issue of the new Ordinary Shares is subject to the new Ordinary Shares beingadmitted to trading on AIM, application for which has been made. Trading in thenew Ordinary Shares, which will rank pari passu in all respects with theexisting ordinary shares, is expected to commence on 17th November 2005. The Company has been informed that it is the intention of the shareholders toretain the vast majority of these shares for the foreseeable future. For further information: Cyprotex PLCRobert Morrisson Atwater Tel: 01625 505152 Code Securities LimitedCharles Walker Tel: 020 7024 2000 Media EnquiriesAbchurch CommunicationsHeather Salmond / Samantha Robbins Tel: 020 7398 7700 This information is provided by RNS The company news service from the London Stock Exchange